Cargando…

Evaluation of Specific IgG Antibody in Subjects Who Had Been Previously Infected with SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Rostami, Soodabeh, Ahangarzadeh, Shahrzad, Zamani Moghaddam, Ali, Nokhodian, Zary, Modaresifar, Hossein, Roustaei, Amirsaman, Shoaei, Parisa, Rowzati, Mohsen, Tahvilian, Zohreh, Nazari, Alireza, Kassaian, Nazila, Haghjooy Javanmard, Shaghayegh, Ataei, Behrooz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410430/ https://www.ncbi.nlm.nih.gov/pubmed/37564435 http://dx.doi.org/10.4103/abr.abr_195_22

Ejemplares similares

SARS-CoV-2 Seroprevalence among Health-Care Workers in Isfahan, Iran
por: Rostami, Soodabeh, et al.
Publicado: (2023)

Current status of COVID-19 pandemic; characteristics, diagnosis, prevention, and treatment
por: Nokhodian, Zary, et al.
Publicado: (2020)

A Process Evaluation of the Isfahan Antibiotic Awareness Campaign: Developing Engagement on Antimicrobial Resistance
por: Rostami, Soodabeh, et al.
Publicado: (2023)

Epidemiology of Bloodstream Infections and Antimicrobial Susceptibility Pattern in ICU and Non-ICU Wards: A Four-Year Retrospective Study in Isfahan, Iran
por: Kassaian, Nazila, et al.
Publicado: (2023)

Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors
por: Nokhodian, Zary, et al.
Publicado: (2012)

Seroprevalence of Hepatitis A in Patients with Chronic Hepatitis C in Isfahan Province
por: Shoaei, Parisa, et al.
Publicado: (2012)

Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers
por: Javadi, Abbasali, et al.
Publicado: (2014)

Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran
por: Kassaian, Nazila, et al.
Publicado: (2012)

Hepatitis C virus infection in patients with hemophilia in Isfahan, Iran
por: Yazdani, Mohammad Reza, et al.
Publicado: (2012)

Comparative Analysis and Identification of Spike Mutations in Iranian COVID-19 Samples from the First Three Waves of Disease
por: Shoaei, Parisa, et al.
Publicado: (2023)

Prevalence of Anti HCV Infection in Patients with Beta-Thalassemia in Isfahan-Iran
por: Ataei, Behrooz, et al.
Publicado: (2012)

Seroprevalence and Risk Factors of Hepatitis C Virus among Juveniles in Correctional Center in Isfahan, Iran
por: Nokhodian, Zary, et al.
Publicado: (2012)

Seroprevalence of hepatitis B markers among incarcerated intravenous drug users
por: Nokhodian, Zary, et al.
Publicado: (2014)

Seroprevalence of hepatitis B virus and human immunodeficiency virus among young prisoners
por: Ataie, Mehdi, et al.
Publicado: (2013)

The prevalence of isolated hepatitis B core antibody and its related risk factors among male injected drug users in Isfahan prisons
por: Shirani, Kiana, et al.
Publicado: (2015)

Identification of Patients with Hepatitis C Virus Infection in Persons with Background of Intravenous Drug Use: The First Community Announcement-based Study From Iran
por: Nobari, Reza Fadaei, et al.
Publicado: (2012)

Isolation of Hepatitis C Virus in Norjizac Vials
por: Tayeri, Katayoon, et al.
Publicado: (2010)

Seroprevalence of Hepatitis B Infection and Associated Risk Factors among Drug Users in Drop-in Centers of Isfahan, Iran
por: Taleban, Roya, et al.
Publicado: (2018)

Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: Seroprevalence and associated factors
por: Kassaian, Nazila, et al.
Publicado: (2011)

HIV and other sexually transmitted infections in women with illegal social behavior in Isfahan, Iran
por: Kassaian, Nazila, et al.
Publicado: (2012)

Efficacy of Hydroxychloroquine in Pre-exposure Severe Acute Respiratory Syndrome Coronavirus 2 Prophylaxis among High-Risk HealthCare Workers: A Multicenter Study
por: Nasri, Elahe, et al.
Publicado: (2023)

Prevalence of Hepatitis B Virus Infection in Isfahan Province
por: Nokhodian, Zary, et al.
Publicado: (2014)

Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran
por: Nokhodian, Zary, et al.
Publicado: (2012)

Novel and emerging mutations of SARS-CoV-2: Biomedical implications
por: Mohammadi, Elmira, et al.
Publicado: (2021)

Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599]
por: Mohammadi, Elmira, et al.
Publicado: (2021)

Risk Prison and Hepatitis B Virus Infection among Inmates with History of Drug Injection in Isfahan, Iran
por: Dana, Daneshmand, et al.
Publicado: (2013)

Dermatophytes contamination of wrestling mats in sport centers of Isfahan, Iran
por: Shadzi, Shahla, et al.
Publicado: (2014)

Seroprevalence of Hepatitis C Infection among Laboratory Health Care Workers in Isfahan, Iran
por: Shoaei, Parisa, et al.
Publicado: (2012)

Association of Clinical Features with Spike Glycoprotein Mutations in Iranian COVID-19 Patients
por: Ahangarzadeh, Shahrzad, et al.
Publicado: (2022)

Surveillance of acute respiratory infections among outpatients: A pilot study in Isfahan city
por: Javadi, Abbasali, et al.
Publicado: (2015)

Mustard gas exposure in Iran–Iraq war – A scientometric study
por: Nokhodian, Zary, et al.
Publicado: (2015)

Epidemiology of Q fever in Iran: A systematic review and meta-analysis for estimating serological and molecular prevalence
por: Nokhodian, Zary, et al.
Publicado: (2017)

High risky behaviors among intravenous drug users in Isfahan, Iran: A study for hepatitis C harm reduction programs
por: Hassannejad, Razieh, et al.
Publicado: (2012)

The assessment of hepatitis B seroprevalence in persons with intravenous drug use history in the Isfahan province: Community-based study
por: Khodadoostan, Mahsa, et al.
Publicado: (2014)

Bacterial Superinfection and Antibiotic Management in Patients with COVID-19 Admitted to Intensive Care Medicine in Central Iran: A Follow-Up Study
por: Nokhodian, Zary, et al.
Publicado: (2023)

Hepatitis B and C among Patients Infected with Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors
por: Ataei, Behrooz, et al.
Publicado: (2010)

Vitamin D Level in Laboratory Confirmed COVID-19 and Disease Progression
por: Dana, Nasim, et al.
Publicado: (2022)

Vaccine design and delivery approaches for COVID-19
por: Shahzamani, Kiana, et al.
Publicado: (2021)

Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases
por: Ataei, Behrooz, et al.
Publicado: (2011)

Letter to Editor
por: Javanmard, Shaghayegh Haghjooy
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bepnbhantnv1i3g2dod5e3ieem